Latest Insider Transactions at Vera Therapeutics, Inc. (VERA)
This section provides a real-time view of insider transactions for Vera Therapeutics, Inc. (VERA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vera Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vera Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 25
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
19,375
-4.23%
|
$930,000
$48.36 P/Share
|
|
Nov 25
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,375
+3.99%
|
$38,750
$2.9 P/Share
|
|
Nov 18
2024
|
Jason S Carter Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,000
+50.0%
|
-
|
|
Nov 13
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
30,625
-3.65%
|
$1,500,625
$49.84 P/Share
|
|
Nov 13
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,625
+3.4%
|
$61,250
$2.9 P/Share
|
|
Oct 28
2024
|
Beth C Seidenberg |
SELL
Open market or private sale
|
Direct |
15,000
-5.13%
|
$720,000
$48.78 P/Share
|
|
Oct 23
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
19,375
-1.53%
|
$794,375
$41.03 P/Share
|
|
Oct 23
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
19,375
+1.48%
|
$38,750
$2.9 P/Share
|
|
Oct 09
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
15,625
-2.45%
|
$593,750
$38.46 P/Share
|
|
Oct 09
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+2.38%
|
$31,250
$2.9 P/Share
|
|
Sep 25
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
23,125
-0.67%
|
$1,063,750
$46.19 P/Share
|
|
Sep 25
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,125
+0.66%
|
$46,250
$2.9 P/Share
|
|
Sep 19
2024
|
Beth C Seidenberg |
SELL
Open market or private sale
|
Direct |
13,823
-8.62%
|
$580,566
$42.31 P/Share
|
|
Sep 18
2024
|
Beth C Seidenberg |
SELL
Open market or private sale
|
Indirect |
1,476
-26.9%
|
$61,992
$42.0 P/Share
|
|
Sep 18
2024
|
Beth C Seidenberg |
SELL
Open market or private sale
|
Direct |
1,177
-0.73%
|
$49,434
$42.01 P/Share
|
|
Sep 11
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
15,625
-2.47%
|
$578,125
$37.55 P/Share
|
|
Sep 11
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+2.41%
|
$31,250
$2.9 P/Share
|
|
Aug 28
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
30,320
-2.3%
|
$1,121,840
$37.17 P/Share
|
|
Aug 28
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+2.22%
|
$31,250
$2.9 P/Share
|
|
Aug 21
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
14,471
-4.29%
|
$564,369
$39.76 P/Share
|
|
Aug 14
2024
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
15,625
-4.43%
|
$578,125
$37.56 P/Share
|
|
Aug 14
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,625
+4.24%
|
$31,250
$2.9 P/Share
|
|
May 16
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
SELL
Open market or private sale
|
Direct |
20,651
-15.41%
|
$867,342
$42.63 P/Share
|
|
May 16
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Exercise of conversion of derivative security
|
Direct |
20,651
+12.6%
|
$144,557
$7.87 P/Share
|
|
May 15
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
SELL
Open market or private sale
|
Direct |
10,186
-8.54%
|
$427,812
$42.42 P/Share
|
|
May 15
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Exercise of conversion of derivative security
|
Direct |
8,221
+11.81%
|
$24,663
$3.94 P/Share
|
|
Apr 10
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
SELL
Open market or private sale
|
Direct |
5,714
-9.7%
|
$228,560
$40.0 P/Share
|
|
Apr 03
2024
|
Sean Grant CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Indirect |
18,649
-47.42%
|
$727,311
$39.16 P/Share
|
|
Apr 03
2024
|
Sean Grant CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
99,828
-19.27%
|
$3,893,292
$39.02 P/Share
|
|
Apr 03
2024
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
99,828
+37.53%
|
$1,397,592
$14.87 P/Share
|
|
Mar 25
2024
|
Maha Katabi |
SELL
Open market or private sale
|
Indirect |
340,000
-10.85%
|
$13,600,000
$40.5 P/Share
|
|
Mar 22
2024
|
Maha Katabi |
SELL
Open market or private sale
|
Indirect |
413,450
-11.65%
|
$16,538,000
$40.51 P/Share
|
|
Mar 21
2024
|
Maha Katabi |
SELL
Open market or private sale
|
Indirect |
81,009
-0.56%
|
$3,564,396
$44.68 P/Share
|
|
Jan 30
2024
|
Maha Katabi |
BUY
Open market or private purchase
|
Indirect |
161,290
+4.26%
|
$4,999,990
$31.0 P/Share
|
|
Jan 16
2024
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
78,750
+19.0%
|
-
|
|
Jan 16
2024
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Grant, award, or other acquisition
|
Direct |
21,875
+27.71%
|
-
|
|
Jan 16
2024
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+25.02%
|
-
|
|
Jan 10
2024
|
Commodore Capital LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,050,000
-19.27%
|
$18,900,000
$18.0 P/Share
|
|
Dec 29
2023
|
Marshall Fordyce PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,516
+2.51%
|
$27,032
$2.61 P/Share
|
|
Dec 20
2023
|
Sean Grant CHIEF FINANCIAL OFFICER |
SELL
Bona fide gift
|
Indirect |
636
-3.41%
|
-
|
|
Aug 21
2023
|
Celia Lin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,490
-11.92%
|
$23,840
$16.65 P/Share
|
|
Aug 21
2023
|
Marshall Fordyce PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
5,210
-2.1%
|
$83,360
$16.66 P/Share
|
|
Aug 21
2023
|
Joanne Curley Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,490
-5.24%
|
$23,840
$16.66 P/Share
|
|
Jul 24
2023
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Bona fide gift
|
Indirect |
1,620
+50.0%
|
-
|
|
Jul 24
2023
|
Sean Grant CHIEF FINANCIAL OFFICER |
SELL
Bona fide gift
|
Indirect |
1,620
-7.99%
|
-
|
|
Jul 05
2023
|
Joseph R Young SVP, FINANCE, CHIEF ACCT OFFCR |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+23.43%
|
$30,000
$3.94 P/Share
|
|
Jun 23
2023
|
Sean Grant CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Indirect |
5,000
+45.49%
|
$80,000
$16.6 P/Share
|
|
Jun 20
2023
|
Commodore Capital LP > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
448,217
+7.6%
|
$6,723,255
$15.17 P/Share
|
|
Mar 30
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
2,300
+0.12%
|
$16,100
$7.24 P/Share
|
|
Mar 28
2023
|
Beth C Seidenberg |
BUY
Open market or private purchase
|
Indirect |
23,908
+1.21%
|
$167,356
$7.24 P/Share
|